CN Stock MarketDetailed Quotes

605116 Aurisco Pharmaceutical

Watchlist
  • 22.17
  • -0.21-0.94%
Market Closed Nov 6 15:00 CST
9.01BMarket Cap23.56P/E (TTM)

About Aurisco Pharmaceutical Company

The company was founded in 1998, focusing on R&D, production and sales of complex APIs and CRO/CDMO of oligonucleic acid drugs. It is an international pharmaceutical enterprise that continues to innovate. The company is registered in Taizhou, Zhejiang, with its operating center in Shanghai and branch companies in Yangzhou, Tianjin and Hangzhou. The company is mainly engaged in R&D, production and sales of specialty complex APIs and pharmaceutical intermediates. It is a pharmaceutical enterprise integrating scientific research, production and sales. The company's main products are raw materials and intermediates for respiratory, cardiovascular, anti-infective, neurological, anti-tumor, and women's health drugs.

Company Profile

Short Name-A奥锐特
Symbol-A605116
Company NameAurisco Pharmaceutical Co.,Ltd.
Listing DateSep 21, 2020
Issue Price8.37
Shares Offered41.00M share(s)
FoundedMar 5, 1998
Listed ExchangeSH Stock Exchange
Legal Representativezhien peng
General Managerdingjun chu
Secretaryfangfang li
Accounting FirmTianjian Certified Public Accountants (Special General Partnership)
Securities Representativecaibing wang
Legal CounselGuo Hao Law Firm (Hangzhou)
Employees657
Phone0576-83170900
Office AddressBadu Industrial Park, Tiantai County, Zhejiang Province
Zip Code317200
Registered AddressBadu Industrial Park, Tiantai County, Taizhou City, Zhejiang Province
Fax0576-83170900
Emailir@aurisco.com
Websitehttp://www.aurisco.com
Business License331000400002854
BusinessR&D and manufacturing of chemical raw materials and chemical products, chemical preparations, chemical raw materials and chemical products (the above products do not include hazardous chemicals and chemicals that are easy to manufacture) and related technical services, technology transfer, after-sales service and warehousing: Chemical products (excluding hazardous chemicals and chemicals that are easy to produce drugs) Sales: Operating the export business of the company's own products and technology and the import business of equipment, spare parts, raw and auxiliary materials and technology required by the enterprise.

Company Executives

  • Name
  • Position
  • Salary
  • zhien peng
  • Chairman, Directors, Strategy Committee Convener
  • 1.36M
  • yizhou chu
  • Vice Chairman, Directors, Member of the Remuneration and Assessment Committee
  • 761.16K
  • jinliang li
  • Directors, Strategy Committee Member, Audit Committee Member
  • 2.05M
  • guoping wang
  • Directors, Deputy General Manager, Strategy Committee Member
  • 1.75M
  • dingjun chu
  • Directors, General Manager, Strategy Committee Member
  • 1.71M
  • peijing qiu
  • Directors, Nomination Committee Members
  • 1.08M
  • weike su
  • Independent Directors, Audit Committee Member, Nomination Committee Convener
  • 40.00K
  • yongcheng zhong
  • Independent Directors, Audit Committee Convener, Member of the Remuneration and Assessment Committee
  • 40.00K
  • yingchun chen
  • Independent Directors, Remuneration and Assessment Committee Convener, Strategy Committee Member, Nomination Committee Members
  • 40.00K
  • fangfang li
  • Board Secretary
  • 1.13M
  • caibing wang
  • Securities Affairs Representative
  • --
  • ping jin
  • Chairman of the Supervisory Board, Auditors
  • 800.88K
  • hang yang
  • Auditors
  • 553.00K
  • mingyan xin
  • Deputy General Manager
  • 816.67K
  • liqin zhang
  • Deputy General Manager
  • 1.29M
  • xiuyu wang
  • Deputy General Manager, Chief Financial Officer
  • 785.98K
  • zhenping zhao
  • Deputy General Manager
  • 906.76K
  • jieming chen
  • Deputy General Manager
  • 867.60K
  • huiping zhao
  • Head of Internal Audit
  • --
  • liwei yang
  • Employee Supervisors
  • 300.83K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data